dc.contributor.advisor |
Knight, S. (Dr.)
|
en |
dc.contributor.author |
Manda, Robert
|
en |
dc.date.accessioned |
2010-11-16T12:51:46Z |
|
dc.date.available |
2010-11-16T12:51:46Z |
|
dc.date.issued |
2009-11 |
|
dc.date.submitted |
2009 |
en |
dc.identifier.citation |
Manda, Robert (2009) Immunological and virological responses in highly active antiretroviral therapy naive patients exposed to isoniazid preventive therapy, University of South Africa, Pretoria, <http://hdl.handle.net/10500/3839> |
en |
dc.identifier.uri |
http://hdl.handle.net/10500/3839 |
|
dc.description.abstract |
This study compare immunological and virological outcomes in antiretroviral therapy naïve patients exposed to Isoniazid prevention treatment.Medical records of antiretroviral naïve patients managed in the public sector from 1st January 2006 to 31st December 2006 were analysed.Multivariate analysis of variance showed that each treatment group achieved statistically significant increases in CD4+ cell count and viral load decay at each follow-up time point. Pairwise post hoc contrast tests showed patients in NVPipt-past group and EFVipt-past group to have superior immunological and virological outcomes respectively. |
en |
dc.format.extent |
1 online resource (143 leaves) |
en |
dc.language.iso |
en |
en |
dc.subject |
Highly active antiretroviral therapy |
en |
dc.subject |
Isoniazid preventive therapy |
en |
dc.subject |
Immunological |
en |
dc.subject |
Virological |
en |
dc.subject.ddc |
616.9792 |
en |
dc.subject.lcsh |
Highly active antiretroviral therapy |
en |
dc.subject.lcsh |
Isoniazid |
en |
dc.subject.lcsh |
Nevirapine |
en |
dc.subject.lcsh |
Immunology |
en |
dc.subject.lcsh |
Virology |
en |
dc.title |
Immunological and virological responses in highly active antiretroviral therapy naive patients exposed to isoniazid preventive therapy |
en |
dc.type |
Dissertation |
en |
dc.description.department |
Health Studies |
en |
dc.description.degree |
M.A. (Public health) |
en |